Skip to main content

BioQuest, Inc. and BotMakers Expand AI Marketing Services with SpeedLeads XL and MarketScope XL

Bioquest Corp. and Botmakers are Partnered to Expand AI Marketing Services with SpeedLead XL and MarketScope XL

KATY, TX / ACCESSWIRE / November 26, 2024 / BioQuest, Inc. (OTC PINK:BQST), soon to complete its acquisition of BotMakers, Inc., is excited to announce the launch of two groundbreaking AI-driven marketing services: SpeedLeads XL and MarketScope XL. These innovative tools leverage cutting-edge artificial intelligence to transform lead generation and advertising, offering businesses unparalleled insights and engagement opportunities with high-intent customers.

The global market for website lead generation solutions has been experiencing exponential growth. With a compound annual growth rate (CAGR) of 17.48%. In the U.S. alone, the digital lead generation market is expected to reach $3.24 billion by 2023, driven by increasing investment in digital marketing and lead generation services. This expanding market underscores the critical role of innovative lead generation technologies, and BioQuest, through BotMakers, is positioned to lead the charge.

SpeedLeads XL: Turning Anonymous Website Visitors into Actionable Leads

SpeedLeads XL identifies anonymous visitors to a company's website, collects their lead data, and immediately initiates an AI-generated phone call to engage with the lead in real time. With access to a data co-operative containing over 300+ million B2B and B2C records, SpeedLeads XL delivers accurate, high-quality leads directly to businesses.

Unique Innovation: BotMakers is one of the first companies to integrate AI voice, SMS, ringless voicemail, and drip email into this type of live lead service. By combining these technologies, SpeedLeads XL offers businesses a seamless and highly engaging multi-channel approach to connect with potential customers.

Key benefits include:

  • Real-Time Engagement: Converts anonymous website visits into actionable leads by initiating automated, personalized phone calls.

  • Enhanced Targeting: Identifies patterns, such as multiple visitors from the same company, signaling strong interest in your offerings.

  • Affordable Pricing: Just $10 per call generated, with a simple $300 activation fee, making it accessible for businesses of all sizes.

  • Multi-Channel Outreach: Combines AI-powered voice calls with SMS, email, and voicemail to ensure comprehensive engagement.

"SpeedLeads XL bridges the gap between website activity and direct engagement," said Tom Hemingway, CEO of BioQuest. "This service enables businesses to connect with potential customers at the right moment, turning curiosity into meaningful conversations. The integration of our data co-operative and multi-channel AI technologies ensures businesses receive reliable, actionable information to drive conversions."

MarketScope XL: The Next Best Thing to Knowing Who is Searching for Your Services

MarketScope XL takes targeted advertising to the next level by identifying high-intent buyers and delivering precision-targeted ad campaigns. With access to more than 200,000 intent signals per second, the AI system identifies potential customers actively searching for specific products or services, such as CFOs seeking payroll solutions or attendees of niche industry conventions.

By analyzing these intent signals, MarketScope XL creates a tailored audience ready to receive your ads and messages. It's the next best thing to knowing exactly who is searching Google or a major search engine for services like yours.

Key features include:

  • High-Intent Audience Identification: AI analyzes real-time intent signals to create customized audiences aligned with your business goals.

  • Omnipresent Ad Campaigns: Combines exclusive advertising data, Demand Side Platform (DSP) access, and Mobile Ad IDs (MAIDs) to deliver targeted ads to your ideal prospects across multiple platforms.

  • Seamless Integration: Creates a sense of omnipresence by ensuring your brand is visible to high-intent prospects wherever they are online.

"MarketScope XL empowers businesses to reach customers who are already searching for what they offer," said Trent Daniel, COO of BioQuest and Co-Founder of BotMakers. "With the combination of AI, real-time data, and multi-channel outreach, our solutions ensure that businesses have the tools they need to thrive in the rapidly growing lead generation market. MarketScope XL delivers the precision and timing that make advertising feel truly personal."

Combining Speed and Precision for Maximum Results

Together, SpeedLeads XL and MarketScope XL redefine lead generation and targeted advertising. Businesses can now engage with leads in real time while simultaneously saturating their target market with precision advertising, creating a cohesive and effective marketing strategy.

Both services will become part of BioQuest's growing portfolio of AI-powered offerings upon completion of its acquisition of BotMakers, Inc.

About BioQuest, Inc.

BioQuest, Inc. (OTC: BQST) is a forward-looking company dedicated to acquiring and advancing innovative technologies. With its impending acquisition of BotMakers, Inc., BioQuest aims to deliver cutting-edge AI solutions to businesses across industries, empowering them to thrive in a rapidly evolving marketplace. Tom Hemingway is the CEO.

Contact:
Tom Hemingway, CEO
bioquest@botmakers.ai
www.bioquestcorp.com

Follow our X account: @bioquestcorp

About BotMakers, Inc.

BotMakers, Inc. is a leader in AI-driven marketing and engagement solutions, specializing in conversational AI and automated outreach technologies. Its services, including SpeedLeads XL and MarketScope XL, empower businesses to streamline customer interactions, optimize lead generation, and execute high-precision advertising campaigns.

Contact: S. Hall
aicallers@botmakers.ai
aitestdrive.us
botmakers.ai

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates, projections, and assumptions made by management. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," and similar expressions are intended to identify such forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such statements. Such risks and uncertainties include, but are not limited to, the ability to successfully integrate the acquisition, execute the growth strategy, raise the necessary funds through the planned Reg A offering, and the general economic conditions affecting the AI industry. BioQuest Corp. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. For additional information on the risks and uncertainties that could affect BioQuest Corp.'s future results, please review the company's filings with the Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

SOURCE: BioQuest



View the original press release on accesswire.com

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.